Screen · Berkshire Criteria

Buffett Quality Screen

Buffett's "wonderful business" criteria, quantified into six dimensions: earnings record (20), ROE quality (25 — Fortune's double standard), low leverage (15), pricing power (15), business stability (15) and capital efficiency (10), for a 0–100 total. The entry gate is the first of Berkshire's acquisition criteria — at least $50M average pre-tax earnings over the last three fiscal years (banks and insurers excluded, as leverage is their business model; investment trusts and closed-end funds excluded, as they are portfolios rather than operating companies). Recomputed periodically from each company's last ten fiscal years; cross-listings merged by canonical ticker. Hover the score for the six-dimension breakdown; companies we cover link to their report. Filtered by score tier "Elite", market cap "Mega ≥$200B", profit streak "≥5 yr": 27 match(clear filters).

# Ticker Mkt Cap Score 10Y ROE Profit Streak Net Debt/Eq Gross Margin Report FY
1 Visa Inc. Class A V · US $684B
95/100 Elite
35.7%low 18.2% 10 yr+ 0.1× 81% Visa Inc. Long-Term Business Owner ResearchMay 25, 2026 · Watch FY2025
2 KLA Corporation KLAC · US $239B
93/100 Elite
55.9%low 44.2% 10 yr+ 0.2× 61% KLA Corporation: A Deep Value Investment AnalysisMay 22, 2026 · Watch FY2026
3 Kweichow Moutai Co Ltd 600519 · Shanghai $236B
93/100 Elite
30.8%low 22.9% 10 yr+ Net cash 90% Kweichow Moutai: A Long-Term Business Owner's PerspectiveMay 21, 2026 · Watch FY2025
4 ASML Holding NV ADR ASML · US $626B
92/100 Elite
36.5%low 15.9% 10 yr+ Net cash 49% ASML Holding NV: A Long-Term Business Owner's PerspectiveMay 20, 2026 · Watch FY2025
5 Applied Materials Inc AMAT · US $403B
92/100 Elite
38.9%low 23.8% 10 yr+ Net cash 46% Applied Materials Deep Value Investment ResearchMay 21, 2026 · Watch FY2025
6 Roche Holding AG ROG · SW $326B
92/100 Elite
39.6%low 26.1% 10 yr+ 0.5× 72% Roche Zen Horizon Framework Deep Dive: A Diagnostics and Pharma Giant Past the Patent Cliff, with a Fair Price and Debated GrowthJun 5, 2026 · Hold FY2025
7 Microsoft Corporation MSFT · US $3.5T
91/100 Elite
34.6%low 20.0% 10 yr+ 0.1× 68% Microsoft: Azure Demand Is Real and the Moat Is Intact, but 393 USD Already Prices a Clean Conversion of the 190 Billion USD Capex WaveJul 29, 2026 · Hold FY2026
8 Lam Research Corp LRCX · US $367B
90/100 Elite
48.3%low 24.3% 10 yr+ Net cash 47% Lam Research from a Long-Term Business Owner's PerspectiveMay 22, 2026 · Watch FY2026
9 American Express Company AXP · US $227B
89/100 Elite
27.8%low 13.6% 10 yr+ 0.3× 87% American Express Closed-Loop Payments Platform ResearchMay 23, 2026 · Watch FY2025
10 Arista Networks ANET · US $227B
88/100 Elite
24.1%low 15.3% 10 yr+ Net cash 64% Arista Networks: A Long-Term Study of the Data Center Switching LeaderMay 23, 2026 · Watch FY2025
11 LOréal S.A. OR · Paris $222B
88/100 Elite
16.5%low 12.3% 10 yr+ 0.1× 73% L’Oréal: Record First-Half Margins and a Broad-Based Recovery, but 30 Times Earnings Already Prices In the China and Gucci UpsideAug 5, 2026 · Hold FY2025
12 Novo Nordisk A/S NOVO-B · CO $210B
88/100 Elite
59.3%low 52.8% 10 yr+ 0.5× 84% Novo Nordisk: A Long-Term Owner's PerspectiveMay 17, 2026 · Watch FY2025
13 Cisco Systems Inc CSCO · US $457B
87/100 Elite
22.4%low 0.3% 10 yr+ 0.3× 63% Cisco Systems: A Value-Investing Deep DiveMay 22, 2026 · Watch FY2025
14 Costco Wholesale Corp COST · US $422B
87/100 Elite
25.4%low 19.5% 10 yr+ Net cash 13% Costco: A Deep-Dive Value Investing AnalysisMay 21, 2026 · Watch FY2025
15 Mastercard Inc MA · US $502B
86/100 Elite
60.0%low 60.0% 10 yr+ 1.0× 77% Mastercard Deep Value Investment ResearchMay 25, 2026 · Watch FY2025
16 Alphabet Inc Class C GOOG · US $4.4T
85/100 Elite
21.7%low 8.3% 10 yr+ Net cash 57% Alphabet: Search and Cloud Are Both Accelerating, but a 200 Billion Dollar Build Has Turned Free Cash Flow Negative and 333.68 Dollars Already Prices In the Base CaseJul 31, 2026 · Hold FY2025
17 Meta Platforms Inc. META · US $1.4T
84/100 Elite
24.3%low 17.3% 10 yr+ 0.0× 82% Meta Platforms: Revenue Grew 28% While Free Cash Flow Fell to 784 Million Dollars, and 556.71 Dollars Buys the Base Case With No Margin of SafetyAug 1, 2026 · Hold FY2025
18 UnitedHealth Group Incorporated UNH · US $376B
84/100 Elite
21.4%low 12.8% 10 yr+ 0.5× 23% UnitedHealth Group (UNH): A Deep-Dive Value Investing StudyMay 25, 2026 · Watch FY2025
19 Procter & Gamble Company PG · US $335B
84/100 Elite
26.6%low 8.3% 10 yr+ 0.4× 50% P&G Deep-Dive Value Research ReportMay 25, 2026 · Watch FY2026
20 Apple Inc. AAPL · US $4.5T
83/100 Elite
54.7%low 35.6% 10 yr+ 0.8× 41% Apple Inc.: Strip Out the Tariff Refunds and the 50.1% Margin Becomes 48.1%, While 308.91 Dollars Earns Less Than the Ten-Year TreasuryAug 1, 2026 · Hold FY2025
21 LVMH Moët Hennessy - Louis Vuitton MC · Paris $253B
83/100 Elite
19.2%low 12.1% 10 yr+ 0.3× 67% FY2025
22 Taiwan Semiconductor Manufacturing TSM · US $2.1T
82/100 Elite
26.3%low 21.8% 10 yr+ Net cash 53% TSMC: Earnings Have Outrun the Share Price to a 28.1x Trailing Multiple, but a Limit-Up Close at NT$2,425 Leaves Only a Limited Margin of SafetyJul 31, 2026 · Hold FY2025
23 Johnson & Johnson JNJ · US $618B
82/100 Elite
25.5%low 2.2% 10 yr+ 0.3× 69% Johnson & Johnson Deep Value Analysis: A Good Company Is Not CheapMay 25, 2026 · Watch FY2025
24 Tencent Holdings Ltd 0700 · HK $548B
82/100 Elite
21.1%low 13.2% 10 yr+ Net cash 48% Tencent Holdings: A Deep Research StudyMay 28, 2026 · Cautious Buy FY2025
25 Texas Instruments Incorporated TXN · US $252B
82/100 Elite
46.2%low 28.4% 10 yr+ 0.6× 63% Texas Instruments Analog and Embedded Processors ResearchMay 23, 2026 · Watch FY2025
26 NVIDIA Corporation NVDA · US $4.9T
81/100 Elite
39.9%low 19.8% 10 yr+ Net cash 64% NVIDIA: Demand Has Broadened Beyond the Hyperscalers, but Its Funding Base Has Not, and 197 USD Already Prices Continued ExcellenceJul 29, 2026 · Hold FY2026
27 Nestle S.A. NESN · SW $265B
80/100 Elite
23.7%low 11.7% 10 yr+ 1.6× 48% FY2025

Data and methodology: the six dimensions quantify Berkshire's published acquisition criteria and Buffett's shareholder letters (1981/1987/1991/2007 among others). Qualitative tests in the originals (e.g. "simple, understandable business", "management in place") are out of scope, and price ("available at a fair price") is covered by each report's valuation range instead. Financials come from company annual reports (via EODHD); ratios are computed in reporting currency, the USD gate via static FX. "‡" marks companies whose equity is persistently negative or tiny (ROE falls back to ROCE); "†" marks missing gross profit (operating margin used). Investment trusts and closed-end funds are excluded on two tests — name and financial shape (operating margins beyond what an operating company can achieve); REITs and operating asset managers are unaffected. This is a quantitative first pass, not investment advice. When citing this data, please credit Zen Horizon (zh.app). See our methodology for the scoring process.